Allergic Rhinitis Forecast in 26 Major Markets 2018-2028 - Analysis & Forecasts Split by Gender & 5 Year Cohort
Comunicato Precedente
Comunicato Successivo
This report provides the current prevalent population for allergic rhinitis across 26 Major Markets (USA,
Canada, France,
Germany, Italy,
Spain, UK, Poland,
Netherlands, Belgium,
Norway, Sweden,
Finland, Denmark,
Austria, Portugal,
Russia, Turkey,
Japan, China,
South Korea, India,
Australia, Brazil,
Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
Providing a value-added level of insight, several features of allergic rhinitis patients, as well as the main symptoms and comorbidities of the disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities of allergic rhinitis include:
Reasons to Buy:
Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/research/brj9wl/allergic_rhinitis?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
